BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ali A, Alzeyoudi SAR, Almutawa SA, Alnajjar AN, Al Dhaheri Y, Vijayan R. Camel Hemorphins Exhibit a More Potent Angiotensin-I Converting Enzyme Inhibitory Activity than Other Mammalian Hemorphins: An In Silico and In Vitro Study. Biomolecules 2020;10:E486. [PMID: 32210030 DOI: 10.3390/biom10030486] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Mu Y, Liu D, Xie H, Zhang X, Han X, Lv Z. Screening and Mechanism of Novel Angiotensin-I-Converting Enzyme Inhibitory Peptides in X. sorbifolia Seed Meal: A Computer-Assisted Experimental Study Method. Molecules 2022;27. [PMID: 36557925 DOI: 10.3390/molecules27248792] [Reference Citation Analysis]
2 Mehmood A, Pan F, Ai X, Tang X, Cai S, Soliman MM, Albogami S, Usman M, Murtaza MA, Nie Y, Zhao L. Novel angiotensin-converting enzyme (ACE) inhibitory mechanism of peptides from Macadamia integrifolia antimicrobial protein 2 (MiAMP2). J Food Biochem 2022;:e14168. [PMID: 35393673 DOI: 10.1111/jfbc.14168] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Todorov P, Georgieva S, Peneva P, Tchekalarova J. Investigation of the structure–activity relationship in a series of new LVV- and VV-hemorphin-7 analogues designed as potential anticonvulsant agents. Amino Acids. [DOI: 10.1007/s00726-021-03112-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
4 Todorov P, Peneva P, Georgieva S, Tchekalarova J, Rangelov M, Todorova N. Synthesis and characterization of new 5,5′-dimethyl- and 5,5′-diphenylhydantoin-conjugated hemorphin derivatives designed as potential anticonvulsant agents. New J Chem 2022;46:2198-217. [DOI: 10.1039/d1nj05235g] [Reference Citation Analysis]
5 Ayoub MA, Vijayan R. Hemorphins Targeting G Protein-Coupled Receptors. Pharmaceuticals (Basel) 2021;14:225. [PMID: 33799973 DOI: 10.3390/ph14030225] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
6 Ali A, Johnstone EKM, Baby B, See HB, Song A, Rosengren KJ, Pfleger KDG, Ayoub MA, Vijayan R. Insights into the Interaction of LVV-Hemorphin-7 with Angiotensin II Type 1 Receptor. Int J Mol Sci 2020;22:E209. [PMID: 33379211 DOI: 10.3390/ijms22010209] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
7 Ali A, Alzeyoudi SAR, Almutawa SA, Alnajjar AN, Vijayan R. Molecular basis of the therapeutic properties of hemorphins. Pharmacol Res 2020;158:104855. [PMID: 32438036 DOI: 10.1016/j.phrs.2020.104855] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.7] [Reference Citation Analysis]